feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Nikkei 225 retreats amid caution

trending

Nasdaq futures rebound: Nvidia earnings

trending

Infosys buyback strengthens shareholder value

trending

Adani acquires Jaiprakash Associates

trending

Excelsoft Technologies IPO oversubscribed

trending

CCRAS Admit Card released

trending

Sydney December weather: wet forecast

trending

IBPS Clerk Prelims Result

trending

NASA: Interstellar comet 3I/ATLAS

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Social Media Fuels Antidepressant Surge in Youth

Social Media Fuels Antidepressant Surge in Youth

20 Nov

•

Summary

  • Antidepressant prescriptions for young people in the UK rose by nearly a third.
  • Social media influencers promote antidepressants as lifestyle aids.
  • Experts warn of unknown side effects and limited effectiveness.
  • 1.8 million people aged 15-29 took antidepressants in England in 2023.
Social Media Fuels Antidepressant Surge in Youth

A significant increase in antidepressant prescriptions among young adults, particularly women, is being observed. In England alone, the number of individuals aged 15 to 29 on these medications rose by nearly a third between 2016 and 2023, reaching over 1.8 million. This trend is partly fueled by social media, where influencers often present antidepressants as a desirable lifestyle choice, showcasing them with appealing hashtags and downplaying adverse effects.

However, mental health professionals express concern over this narrative. Studies suggest antidepressants offer only marginal benefits over placebos and can cause side effects such as emotional numbing, weight gain, and sexual dysfunction. Furthermore, withdrawal symptoms can be severe, with some users reporting persistent issues even after discontinuing the medication. Experts emphasize that alternatives like talking therapies and exercise exist.

The messaging around antidepressants on platforms like TikTok, with billions of views, creates a misconception that they are a simple, harmless aid for everyday stress. This

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
NICE guidelines suggest antidepressants are not effective for mild depression, recommending alternatives like talking therapies.
Influencers often omit side effects like brain fog, weight gain, emotional numbing, and severe withdrawal symptoms.
Social media campaigns and influencer endorsements have significantly driven the rise in antidepressant prescriptions for young adults in the UK.

Read more news on

Healthside-arrow

You may also like

Alzheimer's Hope: Diabetes Drugs Show Promise

13 hours ago • 10 reads

Prozac Fails Kids: New Study Demands Guideline Change

1 hour ago

article image

NHS Offers New Hope for 1,500 Heart Patients

1 hour ago

article image

Childhood Brains Show Surprising Similarities Across Disorders

18 Nov • 10 reads

article image

Opioid Crisis: 500,000 Brits Hooked on Common Meds

18 Nov • 7 reads

article image